Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02802865 · ClinicalTrials.gov registry record · Phase 4
Combined Letrozole and Clomid in Women With Infertility and PCOS
A Phase 4 study, sponsored by Rachel Mejia.
- Completed
- Registry status
- Phase 4
- Development phase
- 70
- Enrollment target
NCT02802865 is a Phase 4 study that has completed, run by Rachel Mejia. The registered enrollment target is 70 participants.
The verdict
NCT02802865, a Phase 4 study, has completed, sponsored by Rachel Mejia.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 70 participants
- Enrollment target
Study Summary
This study evaluates the addition of clomid to letrozole for the treatment of infertility in women with polycystic ovary syndrome. Half of the participants will receive letrozole and clomid in combination, while the other half will receive letrozole alone.
Interventions
- DRUG Letrozole
- DRUG Clomiphene
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2016-08 |
| Est. Completion | 2019-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02802865
The ClinicalTrials.gov registry entry for NCT02802865 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rachel Mejia, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Letrozole is the first listed.
NCT02802865 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02802865 about?
NCT02802865 is a clinical study titled "Combined Letrozole and Clomid in Women With Infertility and PCOS". This study evaluates the addition of clomid to letrozole for the treatment of infertility in women with polycystic ovary syndrome. Half of the participants will receive letrozole and clomid in combination, while the other half will receive letrozole alone.
What is the current status of trial NCT02802865?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 70 participants. The study started on 2016-08. Estimated completion is 2019-02.
What interventions are being tested in trial NCT02802865?
The interventions under investigation include: Letrozole (DRUG), Clomiphene (DRUG).
Who is sponsoring clinical trial NCT02802865?
This trial is sponsored by Rachel Mejia, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.